Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GLUCOSAFE 2 - A New Tool for Nutritional Management and Insulin-therapy in the Intensive Care Unit (ICU): Randomized Controlled Study

NCT03890432 is registered in ClinicalTrials.gov with HEIDEGGER CP as lead sponsor.

NCT NCT03890432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03890432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GLUCOSAFE 2 - A New Tool for Nutritional Management and Insulin-therapy in the Intensive Care Unit (ICU): Randomized Controlled Study
Lead sponsor
HEIDEGGER CP
Phase
Not applicable
Overall status
Completed
Start date
January 10, 2023
Completion date
January 26, 2025
Enrollment
213 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, energy supply; deficiency, severe, hyperglycemia, hypoglycemia, protein deficiency